Author: Totura, Allison L.; Baric, Ralph S.
Title: Reply to “Statins may decrease the Fatality Rate of MERS Infection” Document date: 2015_9_29
ID: tle5jvak_4
Snippet: MyD88 signaling was largely repressed by the use of statins in MERS patients, this could lead to exacerbated compensatory signaling by other innate immune factors, resulting in a poor disease outcome in coronavirus patients. Of critical importance is that the absence of these central TLR adaptor molecules results in increased viral loads that persist for longer periods of time than in wild-type mice following SARS-CoV or MERS-CoV infection (7, 13.....
Document: MyD88 signaling was largely repressed by the use of statins in MERS patients, this could lead to exacerbated compensatory signaling by other innate immune factors, resulting in a poor disease outcome in coronavirus patients. Of critical importance is that the absence of these central TLR adaptor molecules results in increased viral loads that persist for longer periods of time than in wild-type mice following SARS-CoV or MERS-CoV infection (7, 13, 14) . Currently, high viral titers during the acute phase of infection are thought to be a potential factor that increases the likelihood of person-to-person transmission of highly pathogenic coronaviruses. Caution must be used when weighing potential therapeutic options that may increase the likelihood of the spread of these viruses.
Search related documents:
Co phrase search for related documents- acute phase and critical importance: 1, 2, 3
- acute phase and disease outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute phase and immune factor: 1, 2, 3
- acute phase and infection acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- acute phase and long period: 1, 2, 3
- acute phase and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute phase and MERS cov infection: 1, 2, 3
- acute phase and MERS patient: 1
- acute phase and potential factor: 1, 2
- acute phase and therapeutic option: 1, 2, 3, 4, 5, 6, 7, 8
- acute phase and time long period: 1
- acute phase and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acute phase and viral titer: 1
- acute phase and virus spread: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute phase and wild type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- coronavirus patient and critical importance: 1
- coronavirus patient and disease outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- coronavirus patient and long period: 1, 2
- coronavirus patient and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
Co phrase search for related documents, hyperlinks ordered by date